Credit Suisse raised Mead Johnson estimates following the Q3 beat and raised guidance and said weakness in shares due to the internal investigation in China is overdone. The firm sees a "minute" probability that the investigation will impact its business in China or its outlook and views weakness as a buying opportunity. Shares are Outperform rated with a $90 price target.
- Investment & Company Information
- Credit Suisse
- Mead Johnson